Symptom patterns in the daily life of PSC patients
- PMID: 35396817
- PMCID: PMC9325051
- DOI: 10.1111/liv.15271
Symptom patterns in the daily life of PSC patients
Abstract
Background & aims: Patients with primary sclerosing cholangitis (PSC) may suffer from complaints such as pruritus, right upper abdominal quadrant pain (RUQ-A) and fatigue. However, the severity of these complaints, daily and/or seasonal patterns and other factors of influence in PSC are largely unknown. The aim of this study is to assess daily symptoms and patterns thereof in PSC patients in their natural setting.
Methods: A mobile application was designed according to the experience sampling method. Push notifications with a response time of max 4 h were sent during tiers of 3 months. Questions comprised VAS scales on degree of pruritus, fatigue, RUQ-A, time of the day these symptoms were worst, as well as time of intake of medication. Linear mixed modelling was used to identify patient- and external factors associated with pruritus, fatigue and RUQ-A pain.
Results: A total of 6713 questionnaires were completed by 137 patients. Fatigue was the most prevalent symptom among PSC patients being reported in a striking 71% of measurements, followed by pruritus (38%). Both increased during the day and were associated with longer disease duration. A highly significant correlation between pruritus and day temperature was observed (ρ = -0.14, p = .000), and itch was generally worse during winter (p = .000). Patient preference for the tool was high.
Conclusion: Pruritus and fatigue are prevalent symptoms in the daily life of PSC patients and show a distinct diurnal pattern. This may have implications for efficient dosing of anti-pruritic agents. The level of pruritus is highly correlated with day temperature, which may have several implications.
Keywords: cholestatic symptoms; diurnal pattern; experience sampling method; high-density mapping; mobile app.
© 2022 The Authors. Liver International published by John Wiley & Sons Ltd.
Conflict of interest statement
CYP has received research grant funding from Takeda, Gilead and Perspectum, advisory fees from Pliant and Shire and speaker's fees from Takeda, Tillotts. KNM, MGD, ROE and UB declare no conflicts of interest.
Figures




Similar articles
-
The Simple Cholestatic Complaints Score is a valid and quick patient-reported outcome measure in primary sclerosing cholangitis.Liver Int. 2020 Nov;40(11):2758-2766. doi: 10.1111/liv.14644. Liver Int. 2020. PMID: 32841496 Free PMC article.
-
Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.Gastroenterology. 2021 Feb;160(3):734-743.e6. doi: 10.1053/j.gastro.2020.10.001. Epub 2020 Oct 5. Gastroenterology. 2021. PMID: 33031833 Clinical Trial.
-
Fatigue and itch severity in patients with PBC and PSC: Prospective analysis of two large cohorts.Eur J Clin Invest. 2025 Jul;55(7):e70041. doi: 10.1111/eci.70041. Epub 2025 Apr 3. Eur J Clin Invest. 2025. PMID: 40178005
-
Pathogenesis and Management of Pruritus in PBC and PSC.Dig Dis. 2015;33 Suppl 2:164-75. doi: 10.1159/000440829. Epub 2015 Dec 7. Dig Dis. 2015. PMID: 26641452 Review.
-
Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.Liver Int. 2018 Mar;38(3):399-411. doi: 10.1111/liv.13591. Epub 2017 Oct 3. Liver Int. 2018. PMID: 28921801 Review.
Cited by
-
Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective.Aliment Pharmacol Ther. 2025 May;61(10):1612-1621. doi: 10.1111/apt.70054. Epub 2025 Mar 2. Aliment Pharmacol Ther. 2025. PMID: 40025830 Free PMC article.
-
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.Hepatol Commun. 2024 Dec 20;9(1):e0612. doi: 10.1097/HC9.0000000000000612. eCollection 2025 Jan 1. Hepatol Commun. 2024. PMID: 39699308 Free PMC article. Review.
-
Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments.Biomolecules. 2024 Sep 28;14(10):1227. doi: 10.3390/biom14101227. Biomolecules. 2024. PMID: 39456160 Free PMC article. Review.
-
The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization.Sci Rep. 2024 Dec 28;14(1):31433. doi: 10.1038/s41598-024-83085-0. Sci Rep. 2024. PMID: 39732896 Free PMC article.
-
Primary sclerosing cholangitis.Nat Rev Dis Primers. 2025 Mar 13;11(1):17. doi: 10.1038/s41572-025-00600-x. Nat Rev Dis Primers. 2025. PMID: 40082445 Review.
References
-
- Younossi ZM, Kiwi ML, Boparai N, Price LL, Guyatt G. Cholestatic liver diseases and health‐related quality of life. Elsevier. 2000;95(2):497‐502. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Research Materials